Navigation Links
Effective Control Of Blood Sugar Levels

Researchers say about 1 million people in the United States have type 1 diabetes. In type 1 diabetes, the body destroys insulin-producing beta // cells in the pancreas. Intense blood sugar monitoring may help people with type 1 diabetes reduce their risk of nerve damage. Researchers studied more than 1,400 patients with type 1 diabetes. Each participant was assigned to practice either standard or intense diabetes control.

Patients in the standard therapy group checked their blood sugar one or two times daily and gave themselves only one or two injections of insulin. On the other hand, patients in the intensive therapy group checked their blood sugar at least four times a day and had at least three insulin injections a day or treatment with an insulin pump.

Patients who kept intense control of their blood sugar levels for about six years had a lower risk of developing nerve damage. Researchers say they observed that those who stopped the intensive therapy were about one-third less likely to develop nerve damage years later. Thus researchers say that good glucose control should be started as early as possible.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Effective Control Blood Sugar Levels

(Date:11/25/2009)..., LONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgi...undseniorsinthegreaterLongBeachareathankstoFaithIn...ndependenceatHome(IAH),adivisionofSCANHealthPlan.F...dredsofvolunteerstodeliverwarmThanksgivingmealstos...ay,SouthLosAngelesandsurroundingcities. ,, "Our...
(Date:11/25/2009)..., LOSANGELES,Nov.25/PRNewswire-USNewswire/--The...ionstodetermineexecutiveleadershipfor2010. ,, T...thspecialtiesinpublicpolicy,law,finance,government...ip.TheBoardalsocomesfromawiderangeofpersonalbackgr...en,somelivingwithHIVthemselves,andrepresentingmult...
(Date:11/25/2009)..., BroadPoliticalEndorsements,Business,andPress...Newswire-USNewswire/--Onceagain,theNationalBipolar...mationendorsingtheir"Safe,tilStable"program,whichi...ureforbipolardisorder.Today,theNationalBipolarFoun...ExpressPriorityMailfromtheLt.GovernorofLouisianaMi...
(Date:11/25/2009)...esearchers have found evidence of a statistically ...en among patients whose estrogen receptor (ER)-pos... ER-alpha; at serine-118 (ER-alpha S118-P), accord...mber 25 in the Journal of the National Cancer Ins...s are resistant to tamoxifen. Preclinical studies ...
(Date:11/25/2009)...oes stress increase blood pressure? This simple q... many years. New Stress-related gene Modulates Hi...ease blood pressure? This simple question has bee...ow new research has for the first time established...lood pressure response to stress in mice as well a...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...e than normal birth weight or were not breast-fed ...hers. Researchers from the University at Buff...ociation for Cancer Research annual meeting say th...ost important phase of life for the development of...
...n accepted as a hereditary condition.// Rese...e found out the variety of gene that is responsibl...d down this genetic variance to the gene for andro...sport a head full of hair at sixty. The gene ...
...ted that use of narcotics for chronic pain in elde...creasing the dose. On the other hand, the use of t...crease in the dosage with serious health repercuss...nerve damage, fibromyalgia, arthritis and many suc...
...land had fitted the first ptient with a turbocharg...al device is designed to help patients with modera... go for a heart transplant and its related side ef... The new device is a balloon like structure pr...
...e been able to clone human embryos for creating st...diseases or injury. The newly created stem cell li...immune systems. . This research have provid...ave been found suitable to use in treating patient...
...ational neuroscientist of Vanderbilt University ha...ide an insight into neural circuits that play a ro...eural circuits that make us apply previously learn...will also help the scientists in understanding the...
Other Medicine News:
(Date:11/25/2009)...25/PRNewswire-FirstCall/--HeskaCorporation(HSKA);(...specialtyproductstotheveterinaryindustry,announced...hesupplyofbloodgasproductsandaffiliatedconsumables...wscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ...efieldofadvancedpoint-of-carediagnostics,"commente...
(Date:11/25/2009)...25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: ...dtodiscovering,developingandcommercializingnoveldr...forthefiscalyearendedSeptember30,2009.AtSeptember3...entsandshortterminvestments. ,, PipelineUpdate...rial ,, InlateNovember2009,anindependentDataM...
(Date:11/25/2009)...tzerland,Nov.25/PRNewswire/-- FromNovember16-18,Ph...tions,presentedthesecondeditionoftheHearingCarefor...erpopulation.Theconferencebroughttogetherleadingex...han250clinicianswhoworkeverydaywitholderpeoplewith...scussthelatestresearchandtrendsinhearingcareforold...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3QHR and Valley Health Amicably Part Ways 48030 1QHR and Valley Health Amicably Part Ways 48030 2New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 1New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2
...Panelists to Discuss Trends, Trials, and Innovatio... Conferences, CLEVELAND, Sept. 25 Cleveland Clin... on medical innovation and emerging trends,in card...riving the development of new therapies, treat... The 5th annual Cleveland Clinic Medical Inno...
...rena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today a...se 2 clinical trial of APD125 in patients with chr...candidate discovered by Arena that is being,evalua...aining sleep after,initial sleep onset. When compa...ienced statistically significant improvements in m...
Other Medicine Technology:Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 2Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 3Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 5Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 6Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 7
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: